Search results

Biochemical and structural studies to elucidate protein interactions of the new compounds and target molecules included X-ray diffraction at the Australian Synchrotron.

An accomplished international photographer has capture dazzling new images of one component of the main ring at our Australian Synchrotron and provided an inside view of the electron’s path when it is used.

The BRIGHT Nanoprobe beamline provides a unique facility capable of spectroscopic and full-field imaging. NANO will undertake high-resolution elemental mapping and ptychographic coherent diffraction imaging. Elemental mapping and XANES studies (after DCM upgrade) will be possible at sub-100 nm resolution, with structural features able to be studied down to 15 nm using ptychography.

Project Bright, the construction of eight new beamlines at ANSTO’s Australian Synchrotron has reached a milestone by achieving ‘First Light’ for the new micro-computed tomography (MCT) beamline in late NovembeR.

Research represents significant step towards developing vaccine

A new nuclear medicine waste processing facility that showcases ANSTO Synroc technology is under construction.

Ongoing media statements relating to nuclear medicine production.

A world-first processing technology developed in collaboration by ANSTO’s Minerals unit.

Guidance for obtaining and maintaining human or animal ethics approval at the Australian Synchrotron.

The final report on the safety of Building 23 by the independent expert review team has been completed.

With a well-established portfolio of nuclear research and the operation of Australia's only nuclear reactor OPAL, ANSTO scientists conduct both fundamental and applied research on fuel for current, advanced, and future nuclear technology systems.

Devices that use quantum sensors take advantage of quantum properties, unlike conventional instruments that apply classical physics in their operation.